Tyrosine

Modulation of phenylalanine and tyrosine metabolism in HIV-1 infected patients with neurocognitive impairment: results from a clinical trial

To investigate the effects of oral bacteriotherapy on intestinal phenylalanine and tyrosine metabolism, in this longitudinal, double-arm trial, 15 virally suppressed HIV+ individuals underwent blood and fecal sample collection at baseline and after 6 months of oral bacteriotherapy. A baseline fecal sample was collected from 15 healthy individuals and served as control group for the baseline levels of fecal phenylalanine and tyrosine. CD4 and CD8 immune activation (CD38+) was evaluated by flow cytometry.

Complexation of halide ions to tyrosine: role of non-covalent interactions evidenced by IRMPD spectroscopy

The binding motifs in the halide adducts with tyrosine ([Tyr + X]-, X = Cl, Br, I) have been investigated
and compared with the analogues with 3-nitrotyrosine (nitroTyr), a biomarker of protein nitration, in a
solvent-free environment by mass-selected infrared multiple photon dissociation (IRMPD) spectroscopy
over two IR frequency ranges, namely 950–1950 and 2800–3700 cm-1. Extensive quantum chemical
calculations at B3LYP, B3LYP-D3 and MP2 levels of theory have been performed using the 6-311++G(d,p)

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma